G9451 HCV One-Time Screening Reimbursement

HCPCS Level II code G9451 represents a one-time screening for hepatitis C virus (HCV) infection. As a discrete preventive service code, it identifies encounters where a single HCV screening test is performed, supporting public health efforts to detect undiagnosed infections and link patients to care. Nationally, availability and coverage of HCV screening influence early diagnosis, treatment initiation, and downstream cost and quality outcomes.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coverage patterns, typical clinical settings for using G9451, and operational considerations for billing a one-time HCV screen. The publication summarizes how G9451 aligns with preventive screening workflows and the role of a one-time screening code in quality measurement and population health initiatives.

This briefing provides benchmarks and context for coding and billing teams, revenue cycle professionals, and clinical leadership. It highlights where G9451 is commonly applied, expected sites of service, and gaps in available metadata. Data not provided in the input—such as specific payer policy details, associated taxonomies, and ICD-10 mappings—are noted as unavailable.

Billing Code Overview

HCPCS Level II code G9451 denotes a one-time screening for hepatitis C virus (HCV) infection. The service represented is a single-instance HCV screening test, intended to detect HCV infection in patients at the time of the encounter.

Service type: One-time infectious disease screening test

Typical site of service: Outpatient clinic, community screening site, or other ambulatory care settings

Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.

Clinical Context

A patient presents to an outpatient primary care clinic or community screening event for a one-time hepatitis C virus (HCV) screening. Typical candidates include adults born between 1945 and 1965, persons with a history of injection drug use, people with HIV infection, or others with risk factors or prior exposures. The clinician documents counseling about HCV testing, obtains informed consent when required, collects a blood sample for HCV antibody testing (and reflex RNA testing if antibody positive per facility protocol), and records the screening as a one-time preventive service. The visit may be a focused screening encounter without extensive evaluation or a brief preventive visit co‑occurring with other services; billing uses G9451 to indicate the one-time HCV screening occurred. Typical clinical workflow: pre-visit triage identifies screening eligibility, nursing staff obtains brief risk history and phlebotomy, laboratory orders placed for HCV antibody (and reflex HCV RNA if positive), results routed to ordering clinician, and positive results prompt linkage-to-care referral for confirmatory testing and treatment evaluation. Typical sites of service are outpatient clinic, community health screening events, urgent care centers, and federally qualified health centers.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when work required to perform or document the screening is substantially greater than usual (rare for single screening tests).

Taxonomy Code	Specialty	Notes
`207Q00000X`	Family Medicine	Most common primary care specialty performing routine HCV screening.
`208000000X`	Internal Medicine	Primary clinic setting for preventive adult screening.
`363L00000X`	Infectious Disease	Specialty involved for positive confirmatory testing and treatment linkage.
`367A00000X`	Preventive Medicine	Clinicians focused on population screening programs and public health initiatives.
`330M00000X`	Clinical Laboratory	Laboratory director and staff responsible for testing and reflex protocols.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`Z11.59`	Encounter for screening for other viral diseases	Often used to indicate an encounter for screening for HCV when no signs or symptoms are present.
`Z72.89`	Other problems related to lifestyle	May be used when risk behaviors (e.g., injection drug use) are documented as rationale for screening.
`F11.20`	Opioid dependence, uncomplicated	Substance use disorders such as opioid dependence increase HCV risk and justify screening.
`B18.2`	Chronic viral hepatitis C	Used when prior history of chronic HCV infection is known or for follow-up after positive screening and confirmatory testing.
`Z20.828`	Contact with and (suspected) exposure to other viral communicable diseases	Used when screening is performed due to known exposure risk.
`Z13.89`	Encounter for screening for other diseases and disorders	General screening code that may be used in preventive service contexts.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80061`	Lipid panel	Common concurrent preventive laboratory test ordered during the same screening visit.
`36415`	Collection of venous blood by venipuncture	Used to collect the blood specimen for HCV antibody testing during the screening encounter.
`87534`	Infectious agent antigen detection by enzyme immunoassay technique, qualitative or semiquantitative, multiple-step method; hepatitis C virus antibody	Direct laboratory test commonly performed for initial HCV screening when ordered by the clinician.
`87640`	Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe technique (e.g., branched DNA), quantification not specified here	Used for confirmatory HCV RNA testing when the screening antibody is reactive; often performed reflexively after a positive antibody.
`99401`	Preventive medicine counseling, individual, 15 minutes	May be used when counseling regarding screening and results occurs as a separately reportable service during the visit.

OpenPayer

Summary & Overview

HCPCS G9451: One-Time Hepatitis C (HCV) Screening